Understanding the mechanisms by which CD4+CD25+ cells exert their influence during IBDV infection can give us implications for the development of therapeutic strategies for many other diseases including cancer, diabetes, and immune mediated diseases. This evidence concerns the gene CD4 and diabetes mellitus.